Cargando…
Association of Plasma Vitamin D Metabolites With Incident Type 2 Diabetes: EPIC-InterAct Case-Cohort Study
BACKGROUND: Existing evidence for the prospective association of vitamin D status with type 2 diabetes (T2D) is focused almost exclusively on circulating total 25-hydroxyvitamin D [25(OH)D] without distinction between its subtypes: nonepimeric and epimeric 25(OH)D(3) stereoisomers, and 25(OH)D(2), t...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397435/ https://www.ncbi.nlm.nih.gov/pubmed/30418614 http://dx.doi.org/10.1210/jc.2018-01522 |
_version_ | 1783399414795075584 |
---|---|
author | Zheng, Ju-Sheng Imamura, Fumiaki Sharp, Stephen J van der Schouw, Yvonne T Sluijs, Ivonne Gundersen, Thomas E Ardanaz, Eva Boeing, Heiner Bonet, Catalina Gómez, Jesus Humberto Dow, Courtney Fagherazzi, Guy Franks, Paul W Jenab, Mazda Kühn, Tilman Kaaks, Rudolf Key, Timothy J Khaw, Kay-Tee Lasheras, Cristina Mokoroa, Olatz Mancini, Francesca Romana Nilsson, Peter M Overvad, Kim Panico, Salvatore Palli, Domenico Rolandsson, Olov Sieri, Sabina Salamanca-Fernández, Elena Sacerdote, Carlotta Spijkerman, Annemieke M W Stepien, Magdalena Tjonneland, Anne Tumino, Rosario Butterworth, Adam S Riboli, Elio Danesh, John Langenberg, Claudia Forouhi, Nita G Wareham, Nicholas J |
author_facet | Zheng, Ju-Sheng Imamura, Fumiaki Sharp, Stephen J van der Schouw, Yvonne T Sluijs, Ivonne Gundersen, Thomas E Ardanaz, Eva Boeing, Heiner Bonet, Catalina Gómez, Jesus Humberto Dow, Courtney Fagherazzi, Guy Franks, Paul W Jenab, Mazda Kühn, Tilman Kaaks, Rudolf Key, Timothy J Khaw, Kay-Tee Lasheras, Cristina Mokoroa, Olatz Mancini, Francesca Romana Nilsson, Peter M Overvad, Kim Panico, Salvatore Palli, Domenico Rolandsson, Olov Sieri, Sabina Salamanca-Fernández, Elena Sacerdote, Carlotta Spijkerman, Annemieke M W Stepien, Magdalena Tjonneland, Anne Tumino, Rosario Butterworth, Adam S Riboli, Elio Danesh, John Langenberg, Claudia Forouhi, Nita G Wareham, Nicholas J |
author_sort | Zheng, Ju-Sheng |
collection | PubMed |
description | BACKGROUND: Existing evidence for the prospective association of vitamin D status with type 2 diabetes (T2D) is focused almost exclusively on circulating total 25-hydroxyvitamin D [25(OH)D] without distinction between its subtypes: nonepimeric and epimeric 25(OH)D(3) stereoisomers, and 25(OH)D(2), the minor component of 25(OH)D. We aimed to investigate the prospective associations of circulating levels of the sum and each of these three metabolites with incident T2D. METHODS: This analysis in the European Prospective Investigation into Cancer and Nutrition (EPIC)–InterAct case-cohort study for T2D included 9671 incident T2D cases and 13,562 subcohort members. Plasma vitamin D metabolites were quantified by liquid chromatography–mass spectrometry. We used a multivariable Prentice-weighted Cox regression to estimate hazard ratios (HRs) of T2D for each metabolite. Analyses were performed separately within country, and estimates were combined across countries using random-effects meta-analysis. RESULTS: The mean concentrations (SD) of total 25(OH)D, nonepimeric 25(OH)D(3), epimeric 25(OH)D(3), and 25(OH)D(2) were 41.1 (17.2), 40.7 (17.3), 2.13 (1.31), and 8.16 (6.52) nmol/L, respectively. Plasma total 25(OH)D and nonepimeric 25(OH)D(3) were inversely associated with incident T2D [multivariable-adjusted HR per 1 SD = 0.81 (95% CI, 0.77, 0.86) for both variables], whereas epimeric 25(OH)D(3) was positively associated [per 1 SD HR = 1.16 (1.09, 1.25)]. There was no statistically significant association with T2D for 25(OH)D(2) [per 1 SD HR = 0.94 (0.76, 1.18)]. CONCLUSIONS: Plasma nonepimeric 25(OH)D(3) was inversely associated with incident T2D, consistent with it being the major metabolite contributing to total 25(OH)D. The positive association of the epimeric form of 25(OH)D(3) with incident T2D provides novel information to assess the biological relevance of vitamin D epimerization and vitamin D subtypes in diabetes etiology. |
format | Online Article Text |
id | pubmed-6397435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Endocrine Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-63974352019-03-06 Association of Plasma Vitamin D Metabolites With Incident Type 2 Diabetes: EPIC-InterAct Case-Cohort Study Zheng, Ju-Sheng Imamura, Fumiaki Sharp, Stephen J van der Schouw, Yvonne T Sluijs, Ivonne Gundersen, Thomas E Ardanaz, Eva Boeing, Heiner Bonet, Catalina Gómez, Jesus Humberto Dow, Courtney Fagherazzi, Guy Franks, Paul W Jenab, Mazda Kühn, Tilman Kaaks, Rudolf Key, Timothy J Khaw, Kay-Tee Lasheras, Cristina Mokoroa, Olatz Mancini, Francesca Romana Nilsson, Peter M Overvad, Kim Panico, Salvatore Palli, Domenico Rolandsson, Olov Sieri, Sabina Salamanca-Fernández, Elena Sacerdote, Carlotta Spijkerman, Annemieke M W Stepien, Magdalena Tjonneland, Anne Tumino, Rosario Butterworth, Adam S Riboli, Elio Danesh, John Langenberg, Claudia Forouhi, Nita G Wareham, Nicholas J J Clin Endocrinol Metab Clinical Research Articles BACKGROUND: Existing evidence for the prospective association of vitamin D status with type 2 diabetes (T2D) is focused almost exclusively on circulating total 25-hydroxyvitamin D [25(OH)D] without distinction between its subtypes: nonepimeric and epimeric 25(OH)D(3) stereoisomers, and 25(OH)D(2), the minor component of 25(OH)D. We aimed to investigate the prospective associations of circulating levels of the sum and each of these three metabolites with incident T2D. METHODS: This analysis in the European Prospective Investigation into Cancer and Nutrition (EPIC)–InterAct case-cohort study for T2D included 9671 incident T2D cases and 13,562 subcohort members. Plasma vitamin D metabolites were quantified by liquid chromatography–mass spectrometry. We used a multivariable Prentice-weighted Cox regression to estimate hazard ratios (HRs) of T2D for each metabolite. Analyses were performed separately within country, and estimates were combined across countries using random-effects meta-analysis. RESULTS: The mean concentrations (SD) of total 25(OH)D, nonepimeric 25(OH)D(3), epimeric 25(OH)D(3), and 25(OH)D(2) were 41.1 (17.2), 40.7 (17.3), 2.13 (1.31), and 8.16 (6.52) nmol/L, respectively. Plasma total 25(OH)D and nonepimeric 25(OH)D(3) were inversely associated with incident T2D [multivariable-adjusted HR per 1 SD = 0.81 (95% CI, 0.77, 0.86) for both variables], whereas epimeric 25(OH)D(3) was positively associated [per 1 SD HR = 1.16 (1.09, 1.25)]. There was no statistically significant association with T2D for 25(OH)D(2) [per 1 SD HR = 0.94 (0.76, 1.18)]. CONCLUSIONS: Plasma nonepimeric 25(OH)D(3) was inversely associated with incident T2D, consistent with it being the major metabolite contributing to total 25(OH)D. The positive association of the epimeric form of 25(OH)D(3) with incident T2D provides novel information to assess the biological relevance of vitamin D epimerization and vitamin D subtypes in diabetes etiology. Endocrine Society 2018-11-09 /pmc/articles/PMC6397435/ /pubmed/30418614 http://dx.doi.org/10.1210/jc.2018-01522 Text en https://creativecommons.org/licenses/by/4.0/ This article has been published under the terms of the Creative Commons Attribution License (CC BY; https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Copyright for this article is retained by the author(s). |
spellingShingle | Clinical Research Articles Zheng, Ju-Sheng Imamura, Fumiaki Sharp, Stephen J van der Schouw, Yvonne T Sluijs, Ivonne Gundersen, Thomas E Ardanaz, Eva Boeing, Heiner Bonet, Catalina Gómez, Jesus Humberto Dow, Courtney Fagherazzi, Guy Franks, Paul W Jenab, Mazda Kühn, Tilman Kaaks, Rudolf Key, Timothy J Khaw, Kay-Tee Lasheras, Cristina Mokoroa, Olatz Mancini, Francesca Romana Nilsson, Peter M Overvad, Kim Panico, Salvatore Palli, Domenico Rolandsson, Olov Sieri, Sabina Salamanca-Fernández, Elena Sacerdote, Carlotta Spijkerman, Annemieke M W Stepien, Magdalena Tjonneland, Anne Tumino, Rosario Butterworth, Adam S Riboli, Elio Danesh, John Langenberg, Claudia Forouhi, Nita G Wareham, Nicholas J Association of Plasma Vitamin D Metabolites With Incident Type 2 Diabetes: EPIC-InterAct Case-Cohort Study |
title | Association of Plasma Vitamin D Metabolites With Incident Type 2 Diabetes: EPIC-InterAct Case-Cohort Study |
title_full | Association of Plasma Vitamin D Metabolites With Incident Type 2 Diabetes: EPIC-InterAct Case-Cohort Study |
title_fullStr | Association of Plasma Vitamin D Metabolites With Incident Type 2 Diabetes: EPIC-InterAct Case-Cohort Study |
title_full_unstemmed | Association of Plasma Vitamin D Metabolites With Incident Type 2 Diabetes: EPIC-InterAct Case-Cohort Study |
title_short | Association of Plasma Vitamin D Metabolites With Incident Type 2 Diabetes: EPIC-InterAct Case-Cohort Study |
title_sort | association of plasma vitamin d metabolites with incident type 2 diabetes: epic-interact case-cohort study |
topic | Clinical Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397435/ https://www.ncbi.nlm.nih.gov/pubmed/30418614 http://dx.doi.org/10.1210/jc.2018-01522 |
work_keys_str_mv | AT zhengjusheng associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT imamurafumiaki associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT sharpstephenj associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT vanderschouwyvonnet associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT sluijsivonne associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT gundersenthomase associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT ardanazeva associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT boeingheiner associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT bonetcatalina associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT gomezjesushumberto associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT dowcourtney associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT fagherazziguy associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT frankspaulw associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT jenabmazda associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT kuhntilman associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT kaaksrudolf associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT keytimothyj associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT khawkaytee associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT lasherascristina associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT mokoroaolatz associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT mancinifrancescaromana associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT nilssonpeterm associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT overvadkim associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT panicosalvatore associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT pallidomenico associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT rolandssonolov associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT sierisabina associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT salamancafernandezelena associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT sacerdotecarlotta associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT spijkermanannemiekemw associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT stepienmagdalena associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT tjonnelandanne associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT tuminorosario associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT butterworthadams associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT ribolielio associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT daneshjohn associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT langenbergclaudia associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT forouhinitag associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy AT warehamnicholasj associationofplasmavitamindmetaboliteswithincidenttype2diabetesepicinteractcasecohortstudy |